Nanotechnology applications in urology: a review

Abstract

The objectives of this review are to discuss the current literature and summarise some of the promising areas with which nanotechnology may improve urological care. A Medline literature search was performed to elucidate all relevant studies of nanotechnology with specific attention to its application in urology. Urological applications of nanotechnology include its use in medical imaging, gene therapy, drug delivery, and photothermal ablation of tumours. In vitro and animal studies have shown initial encouraging results. Further study of nanotechnology for urological applications is warranted to bridge the gap between preclinical studies and translation into clinical practice, but nanomedicine has shown significant potential to improve urological patient care.

Nano-BTA: A New Strategy for Intravesical Delivery of Botulinum Toxin A

“…Nanoparticles, materials with a scale of 1 to 1,000 nm, have been developed rapidly in recent years. Nanomaterials are versatile in several research fields because of their characteristics, including a high surface-area-to-volume ratio, flexible construction, good biocompatibility, and biodegradability [ 14 ]. Nanomedicine, which incorporates different medical disciplines, has emerged as an especially promising discipline in the field of drug delivery.…”

Nanotechnology combined therapy: tyrosine kinase‐bound gold nanorod and laser thermal ablation produce a synergistic higher treatment response of renal cell carcinoma in a murine model

“…Nanotechnology based treatment of malignancy is in its infancy but is rapidly developing. In genitourinary oncology, the use of nanotechnology as a carrier for drug delivery, laser ablation, gene therapy, and imaging has grown exponentially in the past decade . Nanoparticles serve as excellent drug‐delivery vehicles by isolating chemotherapeutic agents from the systemic environment, allowing for accumulation in solid tumours with leaky vasculature and impaired lymphatics, improving cellular uptake both passively, and through targeted therapy .…”

“…In genitourinary oncology, the use of nanotechnology as a carrier for drug delivery, laser ablation, gene therapy, and imaging has grown exponentially in the past decade . Nanoparticles serve as excellent drug‐delivery vehicles by isolating chemotherapeutic agents from the systemic environment, allowing for accumulation in solid tumours with leaky vasculature and impaired lymphatics, improving cellular uptake both passively, and through targeted therapy . Furthermore, the exploration of nanoparticles in conjunction with temperature‐based therapies, such as laser ablation and high‐intensity focused ultrasound (HIFU), has also been promising .…”

“…Furthermore, the exploration of nanoparticles in conjunction with temperature‐based therapies, such as laser ablation and high‐intensity focused ultrasound (HIFU), has also been promising . Incorporation of particles, such as carbon nanotubes and gold nanorods (AuNRs), with laser irradiation has shown significant improvements in tumour cell kill when compared to laser alone . This effect is in part due to the ability of these compounds to absorb near‐infrared (NIR) radiation and convert this energy into heat for selective ablation .…”